Cargando…
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813119/ https://www.ncbi.nlm.nih.gov/pubmed/33505688 http://dx.doi.org/10.1002/ccr3.3509 |
_version_ | 1783637795644899328 |
---|---|
author | Zaalouk, Tamer Mohamed Bitar, Zouheir Ibrahim Maadarani, Ossama Sajeh Elhabibi, Mohamed Elsayed |
author_facet | Zaalouk, Tamer Mohamed Bitar, Zouheir Ibrahim Maadarani, Ossama Sajeh Elhabibi, Mohamed Elsayed |
author_sort | Zaalouk, Tamer Mohamed |
collection | PubMed |
description | Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome. |
format | Online Article Text |
id | pubmed-7813119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78131192021-01-26 Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome Zaalouk, Tamer Mohamed Bitar, Zouheir Ibrahim Maadarani, Ossama Sajeh Elhabibi, Mohamed Elsayed Clin Case Rep Case Reports Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome. John Wiley and Sons Inc. 2020-11-11 /pmc/articles/PMC7813119/ /pubmed/33505688 http://dx.doi.org/10.1002/ccr3.3509 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Zaalouk, Tamer Mohamed Bitar, Zouheir Ibrahim Maadarani, Ossama Sajeh Elhabibi, Mohamed Elsayed Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title | Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_full | Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_fullStr | Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_full_unstemmed | Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_short | Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
title_sort | carbamazepine‐induced stevens‐johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813119/ https://www.ncbi.nlm.nih.gov/pubmed/33505688 http://dx.doi.org/10.1002/ccr3.3509 |
work_keys_str_mv | AT zaalouktamermohamed carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT bitarzouheiribrahim carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT maadaraniossamasajeh carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome AT elhabibimohamedelsayed carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome |